Insights into the Mode of Action of the Two-Peptide Lantibiotic Haloduracin

por Oman, Trent J., van der Donk, Wilfred A.
Publicado 2009

In Vitro Mutasynthesis of Lantibiotic Analogues Containing Nonproteinogenic Amino Acids

por Levengood, Matthew R., Knerr, Patrick J., Oman, Trent J., van der Donk, Wilfred A.
Publicado 2009

NMR Structure of the S-Linked Glycopeptide Sublancin 168

por Garcia De Gonzalo, Chantal V., Zhu, Lingyang, Oman, Trent J., van der Donk, Wilfred A.
Publicado 2014

Sublancin is not a lantibiotic but an S-linked glycopeptide

por Oman, Trent J., Boettcher, John M., Wang, Huan, Okalibe, Xenia N., van der Donk, Wilfred A.
Publicado 2011

An Engineered Lantibiotic Synthetase That Does Not Require a Leader Peptide on Its Substrate

por Oman, Trent J., Knerr, Patrick J., Bindman, Noah A., Velásquez, Juan E., van der Donk, Wilfred A.
Publicado 2012

Haloduracin α Binds the Peptidoglycan Precursor Lipid II with 2:1 Stoichiometry

por Oman, Trent J., Lupoli, Tania J., Wang, Tsung-Shing Andrew, Kahne, Daniel, Walker, Suzanne, van der Donk, Wilfred A.
Publicado 2011

Non-proteinogenic Amino Acids in Lacticin 481 Analogues Result in More Potent Inhibition of Peptidoglycan Transglycosylation

por Knerr, Patrick J., Oman, Trent J., Garcia De Gonzalo, Chantal V., Lupoli, Tania J., Walker, Suzanne, van der Donk, Wilfred A.
Publicado 2012